Higher specialty training in general surgery in Ireland is a six-year RCSI programme running from ST3 to ST8. The programme covers the specialist interest areas of colorectal surgery, upper gastrointestinal surgery, breast and endocrine surgery, and hepatobiliary and transplant surgery, with trainees eventually sub-specialising in one. Progression is assessed through biannual reviews on the Intercollegiate Surgical Curriculum Programme, and the FRCS exit exam, typically sat in the final two years, is required for the Certificate of Completion of Surgical Training.
Work and interests
General surgeons combine emergency general surgery with a developing interest in colorectal, upper gastrointestinal, breast, endocrine, hepatobiliary or transplant surgery. The work calls for prioritisation, operative judgement and continuity through assessment, treatment and recovery.
Entry and selection for 2027
Entry is through direct progression from CST2 or ESR after completed CST or recognised equivalent training and the MRCS. ESR requires at least 12 months full-time equivalent experience in the chosen specialty, with logbooks, trainer reports, qualification evidence and any required operative-skills/human-factors assessments. Medical Council and English-language eligibility also apply.
For 2027, direct Pathway scoring is CST500 (CAPA/logbook/OSCEs 425 and weighted MRCS PartB75), academic 40 and interview 460, totalling 1000. The five interview weights are 100,40,100,120 and 100 for quality/safety, academic development, current surgical issues, decision making, and professionalism/probity respectively.
ESR uses a separate model: qualifying CST/equivalence earns 0 marks; post-CST clinical experience is assessed out of 45 and academic achievement out of 55, with the combined score rescaled to 600. The five interview stations carry 80 marks each (400 total). Do not add the Pathway and ESR scorecards together.
Both routes require at least 60% pre-interview and 60% overall interview, plus a mandatory 60% pass in decision-making station 4. Passing the aggregate cannot compensate for failing that station. For ESR, reaching 60% does not guarantee an interview; a 3:1 applicant-to-post shortlist may be used.
Applying
July 2027: direct Pathway applications 15 October–13 November 2026. ESR applications open 14 October 2026 at 12 noon and close 13 November 2026 at 12 noon; submit the required hard copy. Eligible academic and final-six-month clinical evidence updates are accepted to 8 January 2027. The ESR form lists 25 March 2027 for interview, subject to confirmation; confirm your individual invitation because the intake guide gives a broader March timetable.